KRTL BioTech

LSE's $27 billion deal rehabilitates Refinitiv debt

LSE's $27 billion deal rehabilitates Refinitiv debt

Financial data firm Refinitiv's $13.5 billion debt, once described as having some of the weakest-ever investor protections typical of the frothy peak of the credit cycle, is being rehabilitated by its $27 billion merger with the London Stock Exchange.